BCM
BPMC

BCK Capital Management’s Blueprint Medicines BPMC Stock Holding History

BCK Capital Management’s Portfolio BPMC Stock Details BPMC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-7,600
Closed -$974K – 91
2025
Q2 		$974K Buy
+7,600
New +$789K 0.84% 39

Other funds holding BPMC

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

BCK Capital Management's BPMC Position: Q3 2025 in Review

BCK Capital Management sold out of Blueprint Medicines (BPMC) in Q3 2025, closing a stake of 7,600 shares — an estimated $974K sold.

BCK Capital Management first reported a position in BPMC in Q2 2025 and held it in 1 quarter. The position peaked at $974K in Q2 2025. 5 funds tracked by Wall St. Rank hold BPMC as of Q3 2025.

  • BCK Capital Management reported no remaining Blueprint Medicines position as of Q3 2025 after selling out during the quarter.
  • BCK Capital Management sold 7,600 Blueprint Medicines shares in Q3 2025, an estimated $974K.
  • BCK Capital Management first reported a position in Blueprint Medicines in Q2 2025 and held it in 1 quarter.
  • BCK Capital Management's Blueprint Medicines position peaked at $974K in Q2 2025.
  • 5 funds tracked by Wall St. Rank held Blueprint Medicines as of Q3 2025.

Based on BCK Capital Management's 13F filing for Q3 2025, filed 10 Nov 2025.